Aditum Bio — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Tempero Bio, Inc.Nov 2025SEC filinghigh confidence
BiotechOakland, US
Christian Klee(Executive Officer)Paul Johnson(Executive Officer, Director)Ricardo Dolmetsch(Executive Officer, Director)Julie Shah(Executive Officer)
Board seatJoseph JimenezJoshua Gertsman· per SEC Form D · $77M raise · filed Nov 2025
Co-investors8VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.